Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 210549
Company: TARO

Products on ANDA 210549

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
AZELAIC ACID	AZELAIC ACID	15%	GEL;TOPICAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 210549

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/23/2019	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/31/2022	SUPPL-5	Labeling-Package Insert		Label is not available on this site.
10/31/2022	SUPPL-4	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 210549

AZELAIC ACID

GEL;TOPICAL; 15%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
AZELAIC ACID	AZELAIC ACID	15%	GEL;TOPICAL	Prescription	No	AB	208011	ACTAVIS LABS UT INC
AZELAIC ACID	AZELAIC ACID	15%	GEL;TOPICAL	Prescription	No	AB	208724	ENCUBE
AZELAIC ACID	AZELAIC ACID	15%	GEL;TOPICAL	Prescription	No	AB	204637	GLENMARK PHARMS
AZELAIC ACID	AZELAIC ACID	15%	GEL;TOPICAL	Prescription	No	AB	210549	TARO
FINACEA	AZELAIC ACID	15%	GEL;TOPICAL	Prescription	Yes	AB	021470	LEO PHARMA AS